The precise genetic diagnosis of a sarcoglycanopathy or dystrophinopathy is sometimes extremely challenging, as pathogenic non-coding variants and/or complex structural variants do exist in DMD or sarcoglycan genes. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.